I ve had it with you and your emotional constipation.

Size: px
Start display at page:

Download "I ve had it with you and your emotional constipation."

Transcription

1 I ve had it with you and your emotional constipation. Washington Irving If Mother had to be told not to put the entire brick of ivory up Junior s hindquarters, constipation is the least of his problems. James Lileks, Highlights from the Golden Age of Bad Parenting Advice

2 I wish that being famous helped prevent me from being constipated. Marvin Gaye America is a constipated nation If you pass small stools, you have to have large hospitals Dennis Burkitt

3 Constipation in older people Dov Gandell MDCM November 2 nd, 2013

4 None Conflicts of Interest

5 Objectives To review the epidemiology, etiology, and definition of constipation in the older adult To review the literature on the treatment of constipation in older people To identify treatment(s) with evidence for improving constipation outcomes in older adults

6 Background Which statement is true? A) Equal numbers of men and women suffer constipation B) The prevalence of community dwelling older adults suffering from constipation is not known C) Constipation is defined as fewer than three bowel movements per week D) Age related changes to anatomy and physiology are not thought to account for most cases of chronic constipation

7 Epidemiology Adult population 14% (95 CI 12% - 17%) Higher prevalence Elderly Community dwelling 20 40% Long term care 50% Lower socioeconomic status Women > Men Mount Sinai Hospital $ yearly in laxative purchases Campbell et al. Factors associated with constipation in a community based sample of people aged 70 years and over. J Epidemiol Community Health 1993;47(1):23 Suares et al. Prevalence of, and Risk Factors for, Chronic Idiopathic Constipation in the Community. Am J Gastroenterol 2011;106:1582

8 Consequences Functional decline Anorexia Nausea Pain Mortality Stercoral ulceration Perforation Wrenn et al. Fecal Impaction. N Engl J Med 1989;321:658 Ouaissi et al. Lethal Fecaloma. J Am Geriatr Soc 2007;55:965

9 Etiology Primary Normal transit - 59% Slow transit - 13% Dyssynergic defecation - 25% Secondary Medications, comorbid disease, metabolic, neoplastic Age-related changes Are not believed to account for symptoms of constipation Nyam et al. Long-term results of surgery for chronic constipation. Dis Colon Rectum 1997:40;273 Camilleri et al. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc 2000:48(9);1142

10 Definition No universally accepted clinical definition Often treated based on patient complaint Gandell et al. (2012). Evidence-Based Geriatric Medicine, A Practical Clinical Guide. (Holroyd-Leduc, Reddy eds.) BMJ Books. Harari et al. How do older persons define constipation? Implications for therapeutic management. J Gen Intern Med 1997;12:63

11 Definition: ROME III criteria 2 of 6 symptoms on at least 25% of bowel movements Straining Lumpy or hard stools Sensation of incomplete evacuation Sensation of anorectal obstruction/blockage Manual maneuvers to facilitate defecation Less than 3 defecations per week Loose stools rarely present without laxative use Insufficient criteria for irritable bowel syndrome Longstreth et al. Functional bowel disorders. Gastroenterology 2006;130(5):

12 Background Which statement is true? A) Equal numbers of men and women suffer constipation B) The prevalence of community dwelling older adults suffering from constipation is not known C) Constipation is defined as fewer than three bowel movements per week D) Age related changes to anatomy and physiology are not thought to account for most cases of chronic constipation

13 Investigations Clinical judgment dictates search for a secondary cause Alarm symptoms Calcium, TSH Digital rectal exam, abdominal plain film Evidence base lacking to guide pursuit of a primary cause $2752 per adult patient Infrequently done prior to a therapeutic trial Rantis et al. Chronic constipation-is the work up worth the cost? Dis Colon Rectum 1997;40:280

14 Treatment options Systematic review, 2012 Age > 65, randomized trial design 16 trials identified Bulk agents (fibres) 7 trials Osmotic agents 4 trials Stimulants 2 trials Stool softeners 1 trial Prokinetics 1 trial Biofeedback 1 trial Gandell et al. Treatment of constipation in older people. CMAJ 2013;185(8):663

15 Results N = 1067 elder participants Mean age 75.9 Setting 323 long term care 280 outpatient setting 91 acute care 80 rehabilitation unit Mean study duration 4 ¾ weeks Gandell et al. Treatment of constipation in older people. CMAJ 2013;185(8):663

16 Results: Bulk Agents Which of the following is true? A) bulk agents can cause allergic reactions B) mechanical GI obstruction has been reported with bulk agents C) beneficial outcomes have not been consistently demonstrated in trials of bulk agents D) bulk agents exert their effect by increasing stool mass and/or volume

17 Bulk Agents Mechanism of action Soluble, non-absorbable dietary fibres hold water in stool Adverse effects Bloating and flatulence Rare allergic reactions and mechanical obstruction Dose Gradually increase to 20 to 30 grams (dietary and supplemental) daily Cost 25 cents per 3 gram dose (Metamucil)

18 Results: Bulk Agents Fibre Psyllium 2 trials Cheskin N = 10 24g daily v. placebo over 4 weeks Stool frequency (SF) 1.3/d v. 0.8/d, p<0.1 Quality score (QS) 2/5 Ewerth N = 10 12g daily v. placebo over 8 weeks SF 0.98/d v. 1.02/d, NS QS 3/5 Sources of bias: blinding, small sample sizes Cheskin et al. J Am Geriatr Soc 1995;43:666 Ewerth et al. Acta Chir Scand Suppl 1980;500:49

19 Results: Bulk Agents Fibre Bran 2 trials Rajala N = 51 Wheat bran in yoghurt twice daily for 2 weeks SF bran 5.9 ± 3.8 per week v. 4.3 ± 1.8, p<0.05 QS 2/5 Sources of bias: blinding, mixture of laxatives Snustad N = 80 10g daily of fibre in cookies SF difference NS QS 2/5 Sources of bias: unknown loss to follow-up Rajala et al. Compr Gerontol [A] 1988;2:83 Snustad et al. J Nutr Elder 1991;10(2):49

20 Results: Bulk Agents Fibre Galactooligosaccharides (GOS) - 3 trials Sairanen N = 43 SF 8.0 ± 0.6/wk GOS v. 7.1 ± 0.5/wk placebo, p=0.011 Surakka N = 42 SF Δ in BM/5 days 0.5 GOS v placebo, p=0.084 Teuri N = 18 SF 7.1/wk GOS (95 CI 3 15) v. 5.9/wk (95 CI 1 to 14) Sairanen et al. Eur J Clin Nutr 2007;61:1423 Surakka et al. Int J Probiotics Prebiotics 2009;4:65 Teuri et al. Ann Nutr Metab 1998;42:319

21 Results: Bulk Agents Which of the following is true? BOTTOM LINE A) bulk agents can cause allergic reactions 1 low quality trial with positive results B) mechanical obstruction has been reported A with reasonable bulk agents choice in ambulatory elders with mild constipation C) beneficial outcomes have not been consistently shown in trials of bulk agents Aim for 20 to 30 grams daily from dietary and supplemental sources D) bulk agents exert their effect by increasing stool mass and/or volume

22 Results: Osmotic Agents Identify the incorrect statement: A) Lactulose is the most effective osmotic laxative B) Magnesium toxicity from magnesium-based laxatives should be considered in some patients C) Polyethylene glycol is available over the counter D) Osmotic laxatives exert their effect by equilibrating colonic and plasma tonicity

23 Osmotic Agents Mechanism of action Promote secretion of water into the colonic lumen to maintain isotonicity with plasma Adverse Effects Bloating, flatulence, diarrhea Dose Polytethylene glycol (PEG) grams/day Lactulose ml daily to twice daily Cost PEG $1 to $2/dose Lactulose $2/dose

24 Results: Osmotic Agents Polyethylene Glycol (PEG) 1 trial Zangaglia N = 57, 7.3g twice daily v. placebo for 8 weeks SF per week 6.6 ± 2.7 PEG v. 3.7 ± 1.9, p<0.002 QS 4/5 Rome criteria as inclusion Randomization not described Zangaglia et al. Mov Disord 2007;22:1239

25 Results: Osmotic Agents Lactulose/Lactitol 3 trials Sanders N = 55, 20g lactulose daily for 12 weeks SF 0.63±0.31/d lactulose v. 0.58±0.3/d, p<0.02 QS 3/5 Sources of bias: randomization, blinding not described Wasselius-De Casparis N = 103, 15ml lactulose daily 50% syrup Success (no use of additional laxatives) 86% lactulose v. 60%, p<0.02 QS 2/5 Sources of bias: follow-up not reported Sanders et al. J Am Geriatr Soc 1978;26:236 Wasselius-De Casparis et al. Gut 1968;9:84

26 Results: Osmotic Agents Lactulose/Lactitol 3 trials Vanderdonckt N = 46, 20g lactitol daily for 4 weeks SF 6 to 7/wk (range) lactitol v. 3 to 4, p<0.001 QS 3/5 Sources of bias: randomization, blinding not described, absence of point estimate Vanderdonckt et al. J Clinical and Exp Gerontol 1990;21:171

27 Results: Osmotic Agents Identify the incorrect statement: BOTTOM A) Lactulose LINE is the most effective osmotic laxative 1 high quality study with a positive result for PEG B) Magnesium toxicity from magnesium-based laxatives should be considered in some patients 3 low to mid quality studies with positive results for Lactulose C) Polyethylene glycol is available over the counter Use of PEG and lactulose in older adults is supported by D) the Osmotic literature laxatives exert their effect by equilibrating colonic and plasma tonicity

28 Results: Stool softeners Regarding stool softeners, choose the correct answer A) They have been shown to improve stool softness according to the Bristol Stool Chart B) Docusate calcium is more effective than docusate sodium and is more convenient with once daily dosing C) The red translucent nature of the capsule helps promote adherence D) They do not have level 1 evidence to support their use

29 Stool softeners Mechanism of action Anionic surfactants easing the interaction of water with solid stool Adverse effects Generally well tolerated Dose Dioctyl sodium sulfosuccinate 100 mg twice daily Docusate calcium 240 mg once or twice daily Cost $0.30 to $0.50 cents per dose

30 Results: Stool softeners Dioctyl Sodium Sulfosuccinate (DSS) 1 trial Hyland N = mg 3 times daily for 4 weeks SF mean difference 1.0±0.29 more stools per week DSS than placebo, p<0.01 Q/S 3/5 Sources of bias: non-constipated participants given placebo excluded from analysis, randomization and blinding not described Hyland et al. Practitioner 1968;200:698

31 Results: Stool softeners Regarding stool softeners, choose correct answer BOTTOM LINE A) They have been shown to improve stool softness The according efficacy to of the stool Bristol softeners Stool is unknown Chart B) Docusate calcium is more potent than docusate sodium and is therefore dosed once instead of twice daily C) The red translucent nature of the capsule helps promote adherence D) They do not have level 1 evidence to support their use

32 Results: Stimulants Stimulants, choose the correct answer A) Melanosis coli is a potential adverse effect that should be screened for with prolonged use B) The maximum recommended daily dose of Senokot is 8 tablets per day C) Stimulants have evidence to support their use in younger adults but not in older adults D) Trials support the use of stimulants when constipation is primarily the result of opioid analgesia

33 Stimulants Mechanism of action Increasing intestinal motility and secretions Adverse effects Abdominal cramps, hypokalemia, pseudomelanosis coli Dose Sennoside up to 68.8 g/d in divided doses Bisacodyl 5 10 mg/d orally or rectally Cost Sennokot $0.15 to $0.20 per tablet

34 Results: Stimulants Sennosides/chinese herbal formulation 2 trials Bub N = 92 20g sennosides for 4 weeks 4.14 more BM over 4 weeks with stimulant than placebo, p=0.017 QS 4/5 Sources of bias: baseline laxatives permitted to continue Huang N = g to 4.5g CCH1 SF per week 5.6±2.0 CCH1 v. 4.6±2.5, p=0.049 QS 3/5 Sources of bias: formulation contained magnesium oxide, randomization and blinding method not reported Bub et al. J Am Med Dir Assoc 2006;7: Huang et al. J Altern Complement Med 2001;17:639-46

35 Results: Stimulants Stimulants, choose the correct answer BOTTOM LINE A) Melanosis coli is a potential adverse effect that should be screened for with prolonged use The efficacy of stimulant laxatives is unknown B) The maximum recommended daily dose of Senokot is 8 tablets per day C) Stimulants have robust evidence to support their use in younger adults but not in older adults D) Trials support the use of stimulants when constipation is primarily the result of opioid analgesia

36 Results: Prokinetics Regarding prokinetics, choose the correct answer A) Cisapride and tegaserod are not related to the current generation prokinetic, prucalopride B) Prucalopride (Resotran) has been approved for use in Canada C) There are multiple trials revealing benefit of prucalopride in older individuals D) Cardiac toxicity should not be a concern

37 Prokinetics Mechanism of action Stimulates the 5-hydroxytryptamine-4 (5-HT 4 ) receptors in the intestine which induces peristalsis Adverse Effects Abdominal pain, diarrhea, nausea, vomiting, flatulence, headache Dose 1 mg daily over 65, 2 mg daily adults Cost $2 - $3 per pill

38 Results: Prokinetics Prucalopride 1 trial N = 300 1,2, or 4 mg once daily for 4 weeks SF week % 3 BM per week v. 26.1%, p< mg dose QS 5/5 Sources of bias: multiple statistical tests, only 1 time point reaching significance for primary outcome Muller-Lissner et al. Neurogastroenterol Motil 2010;22:991-8

39 Results: Prokinetics Regarding prokinetics, choose the correct answer BOTTOM LINE A) Cisapride and tegaserod are not related to the current generation prokinetic, prucalopride The efficacy of prucalopride in older adults is unknown B) Prucalopride (Resotran) has been approved for Adverse events rates from post marketing surveillance will use in Canada be informative C) There are multiple trials revealing benefit of prucalopride in older individuals D) Cardiac toxicity should not be a concern

40 Other noteworthy information Evidence from Younger adults Enemas Fluid intake Exercise

41 American College of Gastroenterology Guidelines Polyethylene glycol Grade A recommendation Increasing stool frequency and consistency Lactulose Grade A recommendation Increasing stool frequency and consistency Psyllium Grade B recommendation Increasing stool frequency Insufficient evidence Other fibres, magnesium, stimulants Brandt et al. Am J Gastroenterol 2005; 100(Suppl. 1):S5 - S21

42 Polyethylene Glycol v. Lactulose Systematic review 10 RCTs comparing PEG and lactulose Adults only recruited in 4/10 studies N = 868 participants 5 trials reported stool frequency per week Taken singularly, all showed that PEG resulted in higher stool frequency per week when compared with lactulose. Elderly subgroup not analyzed Lee-Robichaud et al. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.:CD007570

43 Enemas Long term care RCT Long term care patients, N = 206, mean age g lactulose daily v. 30 g lactulose daily AND glycerine suppository daily tap water enema weekly Primary endpoint at 2 months Mean number of fecal incontinence episodes per patient Lactulose 24±11.5 v. Lactulose and PR 24±10.8, p=0.9 Chassagne et al. Age & Ageing 29(2):

44 Fluid Intake Random selection of elderly, New Mexico Medicare patients Home interview, questionnaire, examination Fluid intake, falls, constipation, fatigue, orthostatic BP N = 883, mean age % felt intake > 6 glasses per day Fluid intake not associated with lying and standing BP Falling frequency of chronic constipation fatigue Lindeman J Gerontol A Biol Sci 2000;55:M361-65

45 Fluid Intake Risk factors for constipation in LTC residents 3 month cohort study of nursing home residents who did not have constipation at baseline 7% developed constipation Poor consumption of fluids OR 1.49 (95 CI ), p<0.001 Not further defined, data from the Minimum Data Set (MDS) Robson et al. Dis Colon Rectum 2000;43:940-43

46 Exercise Long term care RCT N = 157, mean age 81.7, 6 months Resistance training (twice/week) Functional-skills training (twice/week) Combination of above (once each, total twice/week) Education as control group (group discussions) Proportion of constipated subjects at 6 months, NS Resistance 22%, Functional 23%, Combo 29%, Control 9% 20% constipated at baseline Chin A Paw et al. BMC Geriatrics 2006;6:1-9

47

48 In older adults, the evidence reveals polyethylene glycol and lactulose produce more frequent and softer bowel movements than placebo

Constipation an Old Friend. Presented by Dr. Keith Harris

Constipation an Old Friend. Presented by Dr. Keith Harris Constipation an Old Friend Presented by Dr. Keith Harris Irregularity and the Tricks of the Trade." CONSTIPATION What is constipation? INFREQUENT BOWEL MOVEMENTS DIFFICULTY DURING DEFECATION SENSATION

More information

Elderly Man With Chronic Constipation

Elderly Man With Chronic Constipation Elderly Man With Chronic Constipation Linda Nguyen, MD Director, Neurogastroenterology and Motility Clinical Assistant Professor Stanford University Overview Normal bowel function Defining Constipation:

More information

Chronic constipation in the elderly

Chronic constipation in the elderly Chronic constipation in the elderly 1 Dec,2011 R 2 Natta Asanaleykha Epidemiology Definition Scope The impact of chronic constipation in the elderly Pathophysiology Evaluation the elderly patient with

More information

Constipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment

Constipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment CONSTIPATION Constipation An Overview Definition Physiology of GI tract Etiology Assessment Treatment Definition Constipation = the infrequent passage of hard feces Definition of Infrequent The meaning

More information

Efficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club

Efficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club Efficacy and Safety of Lubiprostone Laura Wozniak February 23, 2010 K30 Monthly Journal Club Objectives Brief overview of constipation Review of article Discussion Constipation in Children 3-5% of all

More information

FOOT OFF THE BRAKES. Kerri Novak MD MSc FRCPC. Chronic Constipation: Taking the Foot off the Brakes Dr. Kerri Novak

FOOT OFF THE BRAKES. Kerri Novak MD MSc FRCPC. Chronic Constipation: Taking the Foot off the Brakes Dr. Kerri Novak CHRONIC CONSTIPATION: TAKING THE FOOT OFF THE BRAKES Kerri Novak MD MSc FRCPC www.seacourses.com 1 OUTLINE Epidemiology i Quality of life Approach Therapies www.seacourses.com 2 DEFINING CHRONIC CONSTIPATION

More information

Antidiarrheals Antidiarrheal

Antidiarrheals Antidiarrheal Antidiarrheals Major factors in diarrhea Increased motility of the GI tract. Decreased absorption of fluid. Antidiarrheal drugs include: Antimotility agents. Adsorbents. Drugs that modify fluid and electrolyte

More information

SYMPROIC (naldemedine tosylate) oral capsule

SYMPROIC (naldemedine tosylate) oral capsule SYMPROIC (naldemedine tosylate) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This

More information

Class Review: Drugs for Constipation

Class Review: Drugs for Constipation Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Constipation. What is constipation? What is the criteria for having constipation? What are the different types of constipation?

Constipation. What is constipation? What is the criteria for having constipation? What are the different types of constipation? What is constipation? is defined as having a bowel movement less than 3 times per week. It is usually associated with hard stools or difficulty passing stools. You may have pain while passing stools or

More information

TITLE: Treatments for Constipation: A Review of Systematic Reviews

TITLE: Treatments for Constipation: A Review of Systematic Reviews TITLE: Treatments for Constipation: A Review of Systematic Reviews DATE: 17 November 2014 CONTEXT AND POLICY ISSUES Constipation has many definitions and is often described differently depending on the

More information

Current Pharmacological Treatment Options in Chronic Constipation and IBS with Constipation

Current Pharmacological Treatment Options in Chronic Constipation and IBS with Constipation Current Pharmacological Treatment Options in Chronic Constipation and IBS with Constipation Anthony Lembo, M.D. Associate Professor of Medicine Harvard Medical School Director, GI Motility Center Beth

More information

Scoop on the poop: Constipation in the Elderly

Scoop on the poop: Constipation in the Elderly Scoop on the poop: Constipation in the Elderly Laurie Archbald-Pannone, MD, MPH Assistant Professor Division of General Medicine, Geriatrics, & Palliative Care Division of Infectious Diseases and International

More information

OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES

OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES Introduction Introduction Mean faecal weight 128 g / cap / day Mean range 51-796 g Absolute range 15-1505 g Main factors affecting mass are caloric intake,

More information

Understanding the Prevalence and Impact of Constipation in Canada. A Special Report from the Canadian Digestive Health Foundation

Understanding the Prevalence and Impact of Constipation in Canada. A Special Report from the Canadian Digestive Health Foundation Understanding the Prevalence and Impact of Constipation in Canada A Special Report from the Canadian Digestive Health Foundation February 2014 Understanding the Prevalence and Impact of Constipation in

More information

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 3Q17 July August

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 3Q17 July August BRAND NAME Symproic GENERIC NAME Naldemedine MANUFACTURER Shionogi Inc. DATE OF APPROVAL March 23, 2017 PRODUCT LAUNCH DATE Anticipated to launch mid-summer 2017 REVIEW TYPE Review type 1 (RT1): New Drug

More information

Angie Jefferson Registered Dietitian & Consultant Nutritionist

Angie Jefferson Registered Dietitian & Consultant Nutritionist Angie Jefferson Registered Dietitian & Consultant Nutritionist Constipation & Haemorrhoids are two of the most common problems experienced by pregnant women Incidence increases dramatically 40% women reportedto

More information

Common Gastrointestinal Problems in the Elderly

Common Gastrointestinal Problems in the Elderly Common Gastrointestinal Problems in the Elderly Brian Viviano, D.O. Objectives Understand the pathophysiology, clinical manifestations, diagnosis and management of GI diseases of the elderly. Differentiate

More information

Irritable Bowel Syndrome. Mustafa Giaffer March 2017

Irritable Bowel Syndrome. Mustafa Giaffer March 2017 Irritable Bowel Syndrome Mustafa Giaffer March 2017 Introduction First described in 1771. 50% of patients present

More information

TREATMENT SOCIETY GUIDELINES FOR CONSTIPATION: WHAT IS NEW? FUNCTIONAL CONSTIPATION

TREATMENT SOCIETY GUIDELINES FOR CONSTIPATION: WHAT IS NEW? FUNCTIONAL CONSTIPATION SOCIETY GUIDELINES FOR CONSTIPATION: WHAT IS NEW? Samuel Nurko MD MPH Center for Motility and Functional Gastrointestinal Disorders FUNCTIONAL CONSTIPATION One of the most common functional GI disorders

More information

10/10/16. Disclosures. Educational Objectives

10/10/16. Disclosures. Educational Objectives Nimish Vakil, MD, FACP, FACG, AGAF, FASGE Clinical Adjunct Professor University of Wisconsin Madison, Wisconsin Disclosures All faculty, course directors, planning committee, content reviewers and others

More information

Irritable Bowel Disease. Dr. Alexandra Ilnyckyj MD

Irritable Bowel Disease. Dr. Alexandra Ilnyckyj MD Irritable Bowel Disease Dr. Alexandra Ilnyckyj MD Exactly what is IBS? Common condition affecting mostly women Symptoms are variable but they reflect altered gut movement (motility) and sensation Commonly

More information

MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES

MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES Enrique Rey Professor of Medicine Head. Department of Digestive Diseases Hospital Clínico San Carlos Complutense University Madrid, Spain MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES CONSTIPATION:

More information

Efficacy and Safety of Traditional Medical Therapies for Chronic Constipation: Systematic Review

Efficacy and Safety of Traditional Medical Therapies for Chronic Constipation: Systematic Review American Journal of Gastroenterology ISSN 0002-9270 C 2005 by Am. Coll. of Gastroenterology doi: 10.1111/j.1572-0241.2005.40925.x Published by Blackwell Publishing Efficacy and Safety of Traditional Medical

More information

Primary Care Constipation Guidelines. Version 1 November 2016

Primary Care Constipation Guidelines. Version 1 November 2016 Primary Care Constipation Guidelines Version 1 November 2016 VERSION CONTROL Version Date Amendments made Version 1 November 2016 New guideline Contents 1. Management of constipation in adults: acute and

More information

MANAGING CONSTIPATION

MANAGING CONSTIPATION MANAGING CONSTIPATION INFORMATION FOR OLDER ADULTS, FAMILIES, AND CAREGIVERS READ THIS PAMPHLET TO LEARN: What Constipation is. The Symptoms of Constipation. How to Help Manage Constipation. WHAT IS CONSTIPATION?

More information

Chapter 31 Bowel Elimination

Chapter 31 Bowel Elimination Chapter 31 Bowel Elimination Defecation Defecation: the act of expelling feces from the body Peristalsis: rhythmic contractions of intestinal smooth muscle to facilitate defecation Gastrocolic reflex:

More information

OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA

OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA OMED 17 OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA 29.5 Category 1-A CME credits anticipated ACOFP / AOA s 122 nd Annual Osteopathic Medical Conference & Exposition Joint Session with ACOFP and Cleveland

More information

UNDERSTANDING IBS AND CC Implications for diagnosis and management

UNDERSTANDING IBS AND CC Implications for diagnosis and management UNDERSTANDING IBS AND CC Implications for diagnosis and management J. TACK, M.D., Ph.D. Department of Gastroenterology University Hospitals, K.U. Leuven Leuven, Belgium TYPES OF GASTROINTESTINAL DISORDERS

More information

Drugs Affecting the Gastrointestinal System. Antidiarrheal and Laxatives

Drugs Affecting the Gastrointestinal System. Antidiarrheal and Laxatives Drugs Affecting the Gastrointestinal System Antidiarrheal and Laxatives Diarrhea Abnormal frequent passage of loose stools or Abnormal passage of stools with increased frequency, fluidity, and weight,

More information

Opioid constipation treatment dulcolax

Opioid constipation treatment dulcolax P ford residence southampton, ny Opioid constipation treatment dulcolax Posts about how to relieve constipation instantly written by gbrese1958. Official Web site for MOVANTIK (naloxegol) tablets, for

More information

Prof. Dr. Mufti Munsurar Rahman Dept. of Medicine Enam Medical College Hospital

Prof. Dr. Mufti Munsurar Rahman Dept. of Medicine Enam Medical College Hospital Prof. Dr. Mufti Munsurar Rahman Dept. of Medicine Enam Medical College Hospital Functional constipation : prevalence and life style factors in a district of Bangladesh Perveen I, Rahman MM, Saha M, Parvin

More information

Aging Persons with Intellectual Developmental Disorders (IDD): Constipation KEYPOINTS OVERVIEW

Aging Persons with Intellectual Developmental Disorders (IDD): Constipation KEYPOINTS OVERVIEW Aging Persons with Intellectual Developmental Disorders (IDD): Constipation KEYPOINTS A major medical conditions that commonly is seen among persons with IDD and may lead to serious complications is constipation.

More information

SUPPLEMENTARY INFORMATION Associated with

SUPPLEMENTARY INFORMATION Associated with Table1: Rome III and Rome IV diagnostic criteria for IBS, functional constipation and functional dyspepsia. Rome III diagnostic criteria 1,2 Rome IV diagnostic criteria 3,4 Diagnostic criteria for IBS

More information

Protectives and Adsorbents. Inorganic chemistry Course 1 Third year Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry

Protectives and Adsorbents. Inorganic chemistry Course 1 Third year Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry Protectives and Adsorbents Inorganic chemistry Course 1 Third year 2016-2017 Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry Protectives and Adsorbents This group of gastrointestinal agents

More information

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 2Q17 April May

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 2Q17 April May BRAND NAME Trulance GENERIC NAME Plecanatide MANUFACTURER Synergy Pharmaceuticals, Inc. DATE OF APPROVAL January 19, 2017 PRODUCT LAUNCH DATE Anticipated in 1Q2017 REVIEW TYPE Review type 1 (RT1): New

More information

daily; available as 10- mg g PO

daily; available as 10- mg g PO Overview of the PRN: The Pain and Palliative Care PRN of ACCP is an organization of pharmacy practitioners, clinical scientists, pharmacy educators, and others. Its mission is to advance pain and palliative

More information

Evidence-based Treatment Strategies for

Evidence-based Treatment Strategies for Evidence-based Treatment Strategies for Chronic Constipation William D. Chey, MD Professor of Medicine University of Michigan Rome III criteria*: Chronic constipation Must include 2 of the following (>25%

More information

IBS - Definition. Chronic functional disorder of GI generally characterized by:

IBS - Definition. Chronic functional disorder of GI generally characterized by: IBS - Definition Chronic functional disorder of GI generally characterized by: 3500 3000 No. of Publications 2500 2000 1500 1000 Irritable Bowel syndrome Irritable Bowel Syndrome 500 0 1968-1977 1978-1987

More information

Presenter. Irritable Bowel Syndrome. Objectives. Introduction. Rome Criteria. Irritable Bowel Syndrome 2/28/2018

Presenter. Irritable Bowel Syndrome. Objectives. Introduction. Rome Criteria. Irritable Bowel Syndrome 2/28/2018 Presenter Irritable Bowel Syndrome Current evidence for diagnosis & management Julie Daniels DNP, CNM Assistant Professor Course Coordinator of Primary Care of Women Faculty at Frontier Nursing University

More information

Constipation in children

Constipation in children Search date August 2003 Gregory Rubin QUESTIONS Effects of treatments...397 395 INTERVENTIONS CONSTIPATION Trade off between benefits and harms Cisapride with or without magnesium oxide*...397 Unknown

More information

Appendix H: Prevention of Constipation. Heather Woodbeck, Regional Best Practice Guideline Coordinator for Long Term Care Northwestern Ontario 2007

Appendix H: Prevention of Constipation. Heather Woodbeck, Regional Best Practice Guideline Coordinator for Long Term Care Northwestern Ontario 2007 Appendix H: Prevention of Constipation Heather Woodbeck, Regional Best Practice Guideline Coordinator for Long Term Care Northwestern Ontario 2007 Importance Over ½ of residents in long term care use laxatives

More information

Identify electrolytes that should be monitored whenever prolonged or severe diarrhea is present

Identify electrolytes that should be monitored whenever prolonged or severe diarrhea is present Chapter 35 Drugs Used to Treat Constipation and Diarrhea Learning Objectives State the underlying causes of constipation Explain the meaning of normal bowel habits Cite nine causes of diarrhea Describe

More information

Active ingredients per ml: Docusate sodium 1 mg/sorbitol solution (70%) (crystallising) 357 mg Structural formula: Docusate.

Active ingredients per ml: Docusate sodium 1 mg/sorbitol solution (70%) (crystallising) 357 mg Structural formula: Docusate. NAME OF THE MEDICINE KLYX Enema Active ingredients per ml: Docusate sodium 1 mg/sorbitol solution (70%) (crystallising) 357 mg Structural formula: Docusate Sorbitol C20H37NaO7S MW: 444.56 CAS no: 577-11-7

More information

Authors and Disclosures

Authors and Disclosures Role of Carbon Dioxide-Releasing Suppositories in the Treatment of Chronic Functional Constipation A Double-Blind, Randomised, Placebo-Controlled Trial M. Lazzaroni; V. Casini; G. Bianchi Porro Authors

More information

Constipation in Children. Amani Al Hajeri, MD, CABFM, IBFM, MSc MG*

Constipation in Children. Amani Al Hajeri, MD, CABFM, IBFM, MSc MG* 1 Bahrain Medical Bulletin, Vol. 33, No. 4, December 2011 Education-Family Physician Corner Constipation in Children Amani Al Hajeri, MD, CABFM, IBFM, MSc MG* Constipation in pediatrics age group is frequently

More information

Opioid-Induced Constipation

Opioid-Induced Constipation Objectives Opioid-Induced Constipation Brianna Jansma, PharmD Alex Smith, PharmD Megan Robinson, PharmD Summarize epidemiology of opioid-induced constipation (OIC) Understand opiates effects on the gastrointestinal

More information

Biofeedback for Pelvic Floor Disorders and Incontinence

Biofeedback for Pelvic Floor Disorders and Incontinence The UNC Center for Functional GI & Motility Disorders www.med.unc.edu/ibs Biofeedback for Pelvic Floor Disorders and Incontinence Olafur S. Palsson, Psy.D. Associate Professor of Medicine UNC Center for

More information

ABC s of Bowel Management

ABC s of Bowel Management ABC s of Bowel Management Spina Bifida Education Day Conference SBA of Northeastern New York Albany, New York April 14, 2018 Eric Levey, M.D. Pediatrics & Neurodevelopmental Disabilities Chief Medical

More information

Why does my stomach hurt? Exploring irritable bowel syndrome

Why does my stomach hurt? Exploring irritable bowel syndrome Why does my stomach hurt? Exploring irritable bowel syndrome By Flavio M. Habal, MD, PhD, FRCPC Case In this article: 1. What is IBS? A 45-year-old female is referred to your office with recurrent 2. How

More information

Understanding & Alleviating Constipation. Living (Well!) with Gastroparesis Program Warm-Up Class

Understanding & Alleviating Constipation. Living (Well!) with Gastroparesis Program Warm-Up Class Understanding & Alleviating Constipation Living (Well!) with Gastroparesis Program Warm-Up Class Please Remember The information presented is for educational purposes only and is in no way intended as

More information

Episode 3.2 Show Notes Constipation

Episode 3.2 Show Notes Constipation Episode 3.2 Show Notes Constipation Presented by: Dr Jo Preston, Dr Iain Wilkinson & Mairéad O Malley Faculty: Clare Watson, Wendy Grosvenor Guest faculty: Dr Gaggandeep Singh Alg Broadcast Date: 28th

More information

Emerging Treatments for IBS-C and Clinical Trial Endpoints

Emerging Treatments for IBS-C and Clinical Trial Endpoints Emerging Treatments for IBS-C and Clinical Trial Endpoints Lin Chang, M.D. Oppenheimer Family Center for Neurobiology of Stress David Geffen School of Medicine at UCLA Learning Objectives Describe current

More information

Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary

Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,2 Lotronex (alosetron) a Indication For women with severe diarrheapredominant irritable

More information

Childhood constipation, a real problem..? Marc Benninga, Emma Children s Hospital, AMC, Amsterdam, the Netherlands

Childhood constipation, a real problem..? Marc Benninga, Emma Children s Hospital, AMC, Amsterdam, the Netherlands Childhood constipation, a real problem..? Marc Benninga, Emma Children s Hospital, AMC, Amsterdam, the Netherlands Constipation 0-10% >10-20% >20-30% >30-40% Mugie SM, et al. Best Pract & Res Clin Gastroenterol

More information

Carminatives IBS C 11/12/10. Partial List of Carminatives and Secondary Benefits. Partial List of Carminatives and Secondary Benefits

Carminatives IBS C 11/12/10. Partial List of Carminatives and Secondary Benefits. Partial List of Carminatives and Secondary Benefits IBS C Individuals experience a range of symptoms in addition to constipation (straining and hard stools) but also report abdominal pain and bloating as particularly troubling. Carminatives Estimated average

More information

Constipation. H. David Vargas, MD. Overview

Constipation. H. David Vargas, MD. Overview Constipation H. David Vargas, MD Overview Constipation is a very common complaint affecting upwards of 15% of all Americans. Fortunately, constipation usually is simple to avoid and easy to treat when

More information

Advancing gastroenterology, improving patient care

Advancing gastroenterology, improving patient care American College of Gastroenterology Advancing gastroenterology, improving patient care Note to Visitors: A fully updated ACG Systematic Review on the Management of Chronic Idiopathic Constipation and

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lacrofarm Junior, powder for oral solution, sachet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of contains the following active

More information

Managing constipation in residential care

Managing constipation in residential care Managing constipation in residential care Amanda Lee Lecturer, Hull University ; PhD Candidate, Gastroesophageal cancers Key Points Constipation is a major problem in residential care Early detection and

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Premeeting briefing Prucalopride for the treatment of chronic constipation in women

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Premeeting briefing Prucalopride for the treatment of chronic constipation in women NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Premeeting briefing Prucalopride for the treatment of chronic constipation in women This briefing presents the key issues arising from the manufacturer

More information

Revisionary Capsulorrhaphy Surgery Aftercare Guidelines Following Day Date:

Revisionary Capsulorrhaphy Surgery Aftercare Guidelines Following Day Date: Surgery Sleep in a reclined positon Medications- take as directed Soft Diet and liquids Stool softener/high Fiber foods Leave on all dressing Surgical Stockings First Night Revisionary Capsulorrhaphy Surgery

More information

Constipation a symptom NOT a disease! Bowels/Constipation Documentation The A-B-C-D. Documentation: Bowels/Constipation

Constipation a symptom NOT a disease! Bowels/Constipation Documentation The A-B-C-D. Documentation: Bowels/Constipation Documentation The A-B-C-D Terry Broda, RN(EC), BScN, NPHC,CDDN Elizabeth Kacew, RN(EC), MScN, NP-PHC October 30, 2014 Constipation a symptom NOT a disease! 1 How serious a problem? 50-85% of older people

More information

Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population

Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population Aliment Pharmacol Ther 2005; 22: 483 488. doi: 10.1111/j.1365-2036.2005.02621.x Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population A. O. O.

More information

David Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure:

David Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure: David Leff, DO AOMA 94 th Annual Convention April 13, 2016 Disclosure I have the following financial relationships to disclosure: Speaker s Bureau: Allergan Labs, Takeda Pharmaceutical, Valeant Pharmaceutical

More information

Comparing the efficacy of polyethylene glycol. glycol (PEG), magnesium hydroxide, lactulose. treatment of functional constipation in children

Comparing the efficacy of polyethylene glycol. glycol (PEG), magnesium hydroxide, lactulose. treatment of functional constipation in children Original article Comparing the efficacy of polyethylene glycol (PEG), magnesium hydroxide and lactulosein treatment of functional constipation in children Hossein Saneian 1, Neda Mostofizadeh 2 1 Assistant

More information

Are you aware there are many different reasons for having irregular bowels? This chart is to help you get back into balance during and post detox.

Are you aware there are many different reasons for having irregular bowels? This chart is to help you get back into balance during and post detox. BRISTOL POOP CHART The Bristol Poop Chart was created in the United Kingdom by a group of gastroenterologists at the University of Bristol. This chart is designed to help you determine the health of your

More information

What Is Constipation?

What Is Constipation? CONSTIPATION What Is Constipation? Constipation is when you have infrequent or hard-to-pass bowel movements (meaning they are painful or you have to strain), have hard stools or feel like your bowel movements

More information

William Chey, MD University of Michigan Ann Arbor, MI

William Chey, MD University of Michigan Ann Arbor, MI Lin Chang, MD David Geffen School of Medicine at UCLA Los Angeles, CA William Chey, MD University of Michigan Ann Arbor, MI Mark Pimentel, MD Cedars-Sinai Medical Center Los Angeles, CA Accredited by Jointly

More information

Primary Management of Irritable Bowel Syndrome

Primary Management of Irritable Bowel Syndrome Primary Management of Irritable Bowel Syndrome Jasmine Zia, MD Acting Instructor, Division of Gastroenterology Current Concepts in Drug Therapy CME Course April 23, 2015 Irritable Bowel Syndrome (IBS)

More information

At the outset, we want to clear up some terminology issues. IBS is COPYRIGHTED MATERIAL. What Is IBS?

At the outset, we want to clear up some terminology issues. IBS is COPYRIGHTED MATERIAL. What Is IBS? 1 What Is IBS? At the outset, we want to clear up some terminology issues. IBS is the abbreviation that doctors use for irritable bowel syndrome, often when they are talking about people with IBS. We will

More information

Pharmacy Benefit Determination Policy

Pharmacy Benefit Determination Policy Policy Subject: Opioid Induced Constipation Policy Number: SHS PBD11 Category: GI Agents Policy Type: Medical Pharmacy Department: Pharmacy Product (check all that apply): Group HMO/POS Individual HMO/POS

More information

IBS Irritable Bowel syndrome Therapeutics II PHCL 430

IBS Irritable Bowel syndrome Therapeutics II PHCL 430 Salman Bin AbdulAziz University College Of Pharmacy IBS Irritable Bowel syndrome Therapeutics II PHCL 430 Email:- ahmedadel.pharmd@gmail.com Ahmed A AlAmer PharmD R.S is 32-year-old woman experiences intermittent

More information

Chronic constipation affects up to 63

Chronic constipation affects up to 63 CHRONICALLY QUESTIONED ABOUT CHRONIC CONSTIPATION?* Anthony J. Lembo, MD ABSTRACT Chronic constipation is a common condition that affects more American adults than hypertension, migraine, diabetes, asthma,

More information

Irritable Bowel Syndrome Now. George M. Logan, MD Friday, May 5, :35 4:05 PM

Irritable Bowel Syndrome Now. George M. Logan, MD Friday, May 5, :35 4:05 PM Irritable Bowel Syndrome Now George M. Logan, MD Friday, May 5, 2017 3:35 4:05 PM Dr. Logan indicated no potential conflict of interest to this presentation. He does not intend to discuss any unapproved/investigative

More information

Breast Augmentation Saline Overfilled Surgery Aftercare Guidelines

Breast Augmentation Saline Overfilled Surgery Aftercare Guidelines Surgery Breast Augmentation Saline Overfilled Surgery Aftercare Guidelines First Night Following Day 3-5 Days 1 st Post op Visit 7-10 Days 2 nd Post op Visit 2 Weeks Post op 4-6 Weeks Post op 8-12Weeks

More information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution contains the following active ingredients:

2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution contains the following active ingredients: SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Macrovic Junior powder for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution

More information

Comparison of strategies and goals for treatment of chronic constipation among gastroenterologists and general practitioners

Comparison of strategies and goals for treatment of chronic constipation among gastroenterologists and general practitioners ORIGINAL ARTICLE Annals of Gastroenterology (18) 31, 1-6 Comparison of strategies and goals for treatment of chronic constipation among gastroenterologists and general practitioners Dan Carter a,c, Eytan

More information

Drug Evaluation. Use of lubiprostone in constipating disorders and its potential for opioid-induced bowel dysfunction

Drug Evaluation. Use of lubiprostone in constipating disorders and its potential for opioid-induced bowel dysfunction Use of lubiprostone in constipating disorders and its potential for opioid-induced bowel dysfunction Lubiprostone is a novel medication, approved by the US FDA for the treatment of chronic idiopathic constipation

More information

Constipation Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.uk

Constipation Information Leaflet THE DIGESTIVE SYSTEM.   gutscharity.org.uk THE DIGESTIVE SYSTEM http://healthfavo.com/digestive-system-for-kids.html This factsheet is about Constipation Constipation is a symptom that can mean different things to different people but the usual

More information

A patient s guide to the. management of constipation following surgery

A patient s guide to the. management of constipation following surgery A patient s guide to the management of constipation following surgery This leaflet has been designed to give you more information about using laxatives after your surgery. What is constipation? After your

More information

What s the best buy for treatment of constipation? Results of a systematic review of the efficacy and comparative efficacy of laxatives in the elderly

What s the best buy for treatment of constipation? Results of a systematic review of the efficacy and comparative efficacy of laxatives in the elderly REVIEW ARTICLE What s the best buy for treatment of constipation? Results of a systematic review of the efficacy and comparative efficacy of laxatives in the elderly MARK PETTICREW IAN WATT MICHAEL BRAND

More information

Functional constipation in children: which treatment is effective and safe? An evidence-based case report

Functional constipation in children: which treatment is effective and safe? An evidence-based case report Functional constipation in children: which treatment is effective and safe? An evidence-based case report 1. Private practice, Quebec, Canada. Email: nathaelle@chirostmartin.com By Nathaëlle Martin-Marcotte,

More information

Patient information: Constipation in adults

Patient information: Constipation in adults Page 1 of 9 Official reprint from UpToDate www.uptodate.com 2011 UpToDate Patient information: Constipation in adults Author Arnold Wald, MD Section Editor J Thomas LaMont, MD Deputy Editor Anne C Travis,

More information

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2010;8:838 842 EDUCATION PRACTICE A 27-Year-Old Woman With Constipation: Diagnosis and Treatment ARNOLD WALD Section of Gastroenterology and Hepatology, University

More information

management of this patient within the Enhanced Primary Care Pathway is appropriate, without need for specialist consultation at this time.

management of this patient within the Enhanced Primary Care Pathway is appropriate, without need for specialist consultation at this time. TRIAGE CATEGORY: Enhanced Primary Care Pathway CONSTIPATION Dear Colleague, The clinical and diagnostic information you have provided for the above-named patient is consistent with a diagnosis of chronic

More information

Constipation. Self-study course

Constipation. Self-study course Constipation Self-study course 2 Course objectives: At the end of this course you will be able to: 1. Define the term constipation 2. Explain three reasons why older adults are at greater risk for constipation

More information

Constipation. Myeloma Infosheet Series. Symptoms and complications. Infoline:

Constipation. Myeloma Infosheet Series. Symptoms and complications. Infoline: Constipation This Infosheet explains what constipation is, what causes it in myeloma patients, what the symptoms of it are, how it is treated and some tips for self-management. What is constipation? Constipation

More information

Efficacy and safety of laxatives for chronic constipation in longterm care settings: A systematic review

Efficacy and safety of laxatives for chronic constipation in longterm care settings: A systematic review Received: 6 January 2018 Accepted: 14 May 2018 DOI: 10.1111/jcpt.12721 REVIEW ARTICLE Efficacy and safety of laxatives for chronic constipation in longterm care settings: A systematic review N. Alsalimy

More information

Chapter 19. Assisting With Bowel Elimination. Elsevier items and derived items 2014, 2010 by Mosby, an imprint of Elsevier Inc. All rights reserved.

Chapter 19. Assisting With Bowel Elimination. Elsevier items and derived items 2014, 2010 by Mosby, an imprint of Elsevier Inc. All rights reserved. Chapter 19 Assisting With Bowel Elimination Normal Bowel Elimination Time and frequency of bowel movements (BMs) vary. To assist with bowel elimination, you need to know these terms: Defecation is the

More information

Constipation and bowel obstruction

Constipation and bowel obstruction Constipation and bowel obstruction Constipation Infrequent or difficult defecation with reduced number of bowel movements, which may or may not be abnormally hard with increased difficulty or discomfort

More information

Use of Functional Electrical Stimulation (FES) for chronic constipation & People with Multiple Sclerosis (PwMS)

Use of Functional Electrical Stimulation (FES) for chronic constipation & People with Multiple Sclerosis (PwMS) Use of Functional Electrical Stimulation (FES) for chronic constipation & People with Multiple Sclerosis (PwMS) Christine.singleton@bhamcommunity.nhs.uk Tel: 0121 446 3281 West Midlands Rehabilitation

More information

Constipation. Disease Review

Constipation. Disease Review bowel. 1 Constipation is a symptom, not a disease. Almost everyone experiences Disease Review Constipation Introduction: Constipation is exceedingly common and is rarely associated with mortality in developed

More information

Constipation. What is constipation? What causes constipation? How common is constipation?

Constipation. What is constipation? What causes constipation? How common is constipation? Constipation What is constipation? Constipation is the word we use to describe any difficulty having a bowel movement. This does not just mean infrequent bowel movements, (two or fewer bowel movements

More information

Objectives. Identify age-related changes in the gastrointestinal tract

Objectives. Identify age-related changes in the gastrointestinal tract The Primary Care Physician s Approach to Gastrointestinal Complaints in the Elderly Brian Viviano, D.O. Medical Associates of Erie Objectives Identify age-related changes in the gastrointestinal tract

More information

Oral Methylnaltrexone for the. Constipation in Patients with Chronic Non-cancer Pain

Oral Methylnaltrexone for the. Constipation in Patients with Chronic Non-cancer Pain Oral Methylnaltrexone for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain Richard L. Rauck, 1 John F. Peppin, 2 Robert J.Israel, 3 Jennifer Carpenito, 3 Jeffrey Cohn,

More information

11/04/2011 OVERVIEW. Neurogenic Bowel Management. in adults with Spinal Cord Injury (S.C.I.) Sequence of events in normal Defecation

11/04/2011 OVERVIEW. Neurogenic Bowel Management. in adults with Spinal Cord Injury (S.C.I.) Sequence of events in normal Defecation Neurogenic Bowel Management in adults with Spinal Cord Injury (S.C.I.) Dimitrios D. Ergeletzis MD Physiatrist Director of Physical Medicine & Rehabilitation Dept.- GIROKOMEION ATHENS, Greece OVERVIEW Anatomy

More information

Do Probiotics Provide Adequate Relief From Overall Symptoms, Including Abdominal Pain and Bloating, in Adults With Irritable Bowel Syndrome?

Do Probiotics Provide Adequate Relief From Overall Symptoms, Including Abdominal Pain and Bloating, in Adults With Irritable Bowel Syndrome? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Do Probiotics Provide Adequate Relief

More information

Foreword. Bowel Management

Foreword. Bowel Management 2 Bowel Management Foreword The section on is very similar to that of Bladder Care and Management section, as there are many issues to be addressed. You should always remember that what works for one individual

More information

Opioids: Safe Use and Side Effects

Opioids: Safe Use and Side Effects Opioids: Safe Use and Side Effects Your doctor has prescribed an opioid (OHpee-oyd). This drug can control moderate to severe pain without increased risk of bleeding and kidney problems. Always take the

More information